HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reticulocytosis

An increase in circulating RETICULOCYTES, which is among the simplest and most reliable signs of accelerated ERYTHROCYTE production. Reticulocytosis occurs during active BLOOD regeneration (stimulation of red bone marrow) and in certain types of ANEMIA, particularly CONGENITAL HEMOLYTIC ANEMIA.
Also Known As:
Reticulocytoses
Networked: 507 relevant articles (15 outcomes, 16 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Anemia
2. Hemolysis
3. Hyperbilirubinemia
4. Pernicious Anemia
5. Leukemia

Experts

1. Little, Jane A: 3 articles (11/2020 - 09/2016)
2. Meier, Emily Riehm: 3 articles (01/2020 - 01/2013)
3. Kalfa, Theodosia A: 3 articles (01/2019 - 12/2006)
4. Stevenson, Mary M: 3 articles (01/2014 - 02/2004)
5. Tam, Mifong: 3 articles (01/2014 - 02/2004)
6. Luzzatto, Lucio: 2 articles (01/2021 - 01/2016)
7. Gurkan, Umut A: 2 articles (11/2020 - 06/2018)
8. Ilich, Anton: 2 articles (11/2020 - 06/2018)
9. Key, Nigel S: 2 articles (11/2020 - 06/2018)
10. Kucukal, Erdem: 2 articles (11/2020 - 06/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Reticulocytosis:
1. Hemoglobins (Hemoglobin)IBA
2. alpha-GlobinsIBA
3. Vitamin EFDA LinkGeneric
4. Cyclophosphamide (Cytoxan)FDA LinkGeneric
5. Coloring Agents (Dyes)IBA
6. gamma-GlobinsIBA
7. SodiumIBA
8. Messenger RNA (mRNA)IBA
9. Prednisone (Sone)FDA LinkGeneric
10. LectinsIBA

Therapies and Procedures

1. Therapeutics
2. Retreatment
3. Thymectomy
4. Plasmapheresis
5. Plasma Exchange